Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
Share:
More In Business
Cheddar Morning News Briefings of May 10th
Cheddar Morning News Briefings
Airbnb Warns of Possible Slowdown in Bookings
Airbnb warned in its latest quarterly report of a possible slowdown in bookings. Cheddar News breaks down how budget-conscious customers are planning changes in travel for the upcoming summer season.
How to Take Advantage of 529 College Plans
How to Take Advantage of 529 College Plans
Amazon Begins Offering Physical Products in Video Games, Virtual Reality
Amazon said Tuesday it launched a new service that will allow customers to purchase physical products while playing video games or interacting in virtual reality.
Be Well: How to Tap Into Your Self-Care Mindset
Be Well: How to Tap Into Your Self-Care Mindset
Be Well: Hot Ticket Health & Wellness Summer Essentials
Be Well: Hot Ticket Health & Wellness Summer Essentials
What To Do With Large Stock Positions
Some people have a large single stock position from a company they used to work at... but not everyone knows what to do with it. Gina DeRaimo, SVP, Head of The Options Institute at Cboe Global Markets, joins Cheddar News to break down what you can do with large stock positions.
Cheddar Afternoon News Briefings of May 9th
Cheddar Afternoon News Briefings
Tempur Sealy to Buy Mattress Firm in $4 Billion Deal
Tempur Sealy has agreed to acquire Mattress Firm in a cash-and-stock transaction valued at about $4 billion.
